News | Breast Biopsy Systems | February 18, 2026

The Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy System is designed to be positioned in the MRI scanner room,

beast biopsy, mri,

Prima MR System (Photo: Mammotome)


Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy System, the industry's first system designed to be positioned in the MRI scanner room, at the patient's side during a breast biopsy procedure. This enhances clinician coordination, improves communication and keeps the focus on patient care by bringing the vacuum-assisted breast biopsy device directly into the room.

The Mammotome Prima MR system streamlines workflow with an intuitive in-room design1. Clinicians benefit from larger tissue samples2 enabled by stronger vacuum3 and an 8-gauge needle. This is made possible by 75% less tubing compared to other systems4. Less tubing also results in faster setup and cleanup and less biohazard waste. Additional highlights include convenient aperture size and vacuum strength adjustments on a touchscreen interface.

Ultimately, these combined benefits ensure clinicians can focus on delivering safe, accurate and compassionate care, translating into a better experience for patients. "Our commitment to advancing breast care drives every innovation we bring to market," said Scott Treml, Mammotome Vice President and General Manager. "As the first of its kind in-room solution, the Mammotome Prima MR system empowers clinicians with greater efficiency and confidence, ultimately improving the patient experience."

The Mammotome Prima MR system has secured CE mark, and first cases are underway in select European countries. The system will debut at the European Society of Radiology (ECR) Congress in March. Mammotome will be expanding access in select global markets throughout 2026.

To learn more, please visit the Mammotome website.

References

  1. Compared to the Hologic ATEC system based on a survey of 16/16 (100%) MRI technologists currently using the Hologic ATEC system, after using the Mammotome Prima system.
  2. Mammotome Prima MR 8G probe compared to the Hologic ATEC 9G yielded 78.6% higher average sample weight based on porcine lab data from 120 tissue samples for each group of devices.
  3. Measured at the aperture, compared to the Hologic ATEC breast biopsy system based on benchtop testing.
  4. Compared to the Hologic ATEC standard MR probe tubing and the BD Encor Enspire MR probe with tubing extension.

Related Content

News | Breast Imaging

April 15, 2026 — QT Imaging Holdings, Inc. has launched its QTI Imaging-Olea Viewer, developed in collaboration with ...

Time April 15, 2026
arrow
News | Breast Imaging

April 1, 2026 — QT Imaging Holdings has released its latest image reconstruction software update, version 4.5.0. This ...

Time April 02, 2026
arrow
News | Ultrasound Imaging

March 30, 2026 — Butterfly Network, Inc. has received clearance from the U.S. Food and Drug Administration (FDA) for a ...

Time April 01, 2026
arrow
News | Breast Imaging

March 30, 2026 — Each year, the Alumni Association at the University of Missouri-Kansas City, recognizes the ...

Time March 31, 2026
arrow
News | MRI Breast | Breast cancer, dense breast, MRI

March 2, 2026 — A collaborative modeling study found that adding biennial breast magnetic resonance imaging (MRI) to ...

Time March 20, 2026
arrow
News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
Subscribe Now